Correction To: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention

Cardiovascular Toxicology - United States
doi 10.1007/s12012-018-9475-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions

Clinical Pharmacology and Therapeutics
Pharmacology
2011English

Resistance to Antiplatelet Drugs (Aspirin, Clopidogrel) in Patients Undergoing Elective Percutaneous Coronary Intervention

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2012English

Rationale and Role of High Loading Dose Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Pharmacology & Pharmacy
2012English

Clopidogrel Non-Responsiveness in Patients Undergoing Percutaneous Coronary Intervention Using the VerifyNow Test: Frequency and Predictors

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2017English

Changes of High Sensitivity C-Reactive Protein During Clopidogrel Therapy in Patients Undergoing Percutaneous Coronary Intervention

Research in Cardiovascular Medicine
2015English

Mean Platelet Volume in Patients Undergoing Percutaneous Coronary Intervention

Platelets
MedicineHematology
2013English

Percutaneous Mechanical Circulatory Support Devices in High-Risk Patients Undergoing Percutaneous Coronary Intervention

Medicine
Medicine
2019English

Predictors of In-Stent Restenosis in Patients Undergoing Percutaneous Coronary Intervention

Demiroğlu Bilim University Florence Nightingale Journal of Medicine
2019English

Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy